Long-term outcome of intravitreal pegaptanib sodium as maintenance therapy in Japanese patients with neovascular age-related macular degeneration (Q86857727)

From Wikidata

Jump to navigation Jump to search

scientific article published on 04 March 2015

Language	Label	Description	Also known as
English	Long-term outcome of intravitreal pegaptanib sodium as maintenance therapy in Japanese patients with neovascular age-related macular degeneration	scientific article published on 04 March 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Long-term outcome of intravitreal pegaptanib sodium as maintenance therapy in Japanese patients with neovascular age-related macular degeneration (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

macular degeneration

1 reference

based on heuristic

inferred from title

author name string

Maiko Inoue

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Kazuaki Kadonosono

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Akira Arakawa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Shin Yamane

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Tatsuro Ishibashi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

4 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Japanese Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

59

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

173-178

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25733493%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety in Aflibercept versus Ranibizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-related macular degeneration is the leading cause of blindness...

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of switching therapy to pegaptanib in eyes with the persistent cases of exudative age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance therapy with pegaptanib sodium for neovascular age-related macular degeneration: an exploratory study in Japanese patients (LEVEL-J study).

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegaptanib for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrovascular accidents in ranibizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

1 reference

https://pubmed.ncbi.nlm.nih.gov/25733493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86857727&oldid=2221894845"